Fair value · Sanofi (SNY) · updated 2026-11-19 · from 20-F FY2025
Sanofi trades at $46.88. We are not reading assumptions out of that price: our price is for one ADS, which represents 0.5 ordinary shares, but this company files its per-share figures per ordinary share — so these methods need a per-share restatement we do not yet publish.
Everything below is unaffected: the filed statements, the filing they came from, and SNY’s growth history are all as reported.
Inputs come from the FY2025 20-F filed (accession 0001628280-26-008403); set your own on the sliders below. Research, not investment advice.
The filing behind these numbers
Sanofi- Revenue
- EUR 43.6B
- Diluted EPS
- EUR 6.37
- Free cash flow
- EUR 7.2B
- operating cash flow − capital expenditure
- Diluted shares
- 1.23B
- weighted average
20-F FY2025 · fiscal year ended 2025-12-31 · filed 2026-02-17 · accession 0001628280-26-008403
Open this filing on sec.govNeed SNY data in your own agent or pipeline?
The valuation data behind this page — DCF fair value, margin of safety, PE vs industry, analyst estimates — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.